FIELD: medicine.
SUBSTANCE: group of inventions refers to application of nerve growth factor (NGF) antibodies (anti-NGF antibodies) for pain management, physical function improvement and rigidity decrease in an individual suffering osteoarthritis. There are presented: a method of pain management, physical function improvement and rigidity decrease in an individual suffering osteoarthritis involves administration to the specified individual of an effective amount of anti-NGF antibodies, and also a kit and a pharmaceutical composition for implementing such method of management.
EFFECT: pain relief, physical function improvement and rigidity decrease in the patients suffering osteoarthritis.
24 cl, 23 tbl, 9 ex, 27 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OF INTERSTITIAL CYSTITIS | 2008 |
|
RU2570559C2 |
| STABLE LIQUID PREPARATION OF ANTIBODY | 2009 |
|
RU2518278C2 |
| METHOD OF TREATMENT OF POSTOPERATIVE PAIN BY ADMINISTERING OF ANTAGONIST OF FACTOR OF GROWTH OF NERVES AND COMPOSITIONS CONTAINING FACTOR OF GROWTH OF NERVES | 2003 |
|
RU2338555C2 |
| ANTIBODIES AGAINST NERVE GROWTH FACTOR AND METHODS FOR THEIR PRODUCTION AND APPLICATION | 2012 |
|
RU2644235C2 |
| CHIMERIC PROTEIN COMPOSED OF NGF ANTAGONIST DOMAIN AND TNFα ANTAGONIST DOMAIN | 2015 |
|
RU2678810C2 |
| NGF ANTIBODIES AND RELATED METHODS | 2019 |
|
RU2838175C2 |
| ANTIBODIES AGAINST NERVE GROWTH FACTOR AND METHODS FOR THEIR PRODUCTION AND APPLICATION | 2012 |
|
RU2640252C2 |
| ANTIBODIES AGAINST NERVE GROWTH FACTOR AND METHODS FOR THEIR PRODUCTION AND APPLICATION | 2012 |
|
RU2640254C2 |
| METHODS OF TREATING CHRONIC PAIN | 2009 |
|
RU2522493C2 |
| ANTAGONIST ANTI-IL-7 RECEPTOR ANTIBODIES AND METHODS | 2011 |
|
RU2533809C9 |
